Gruppo Italiano Mammella (GIM) 10-CONSENT: A phase III randomized study comparing concurrent versus sequential administration of adjuvant chemotherapy (CT) and aromatase inhibitors (AIs) in post-menopausal patients (pts) with hormone receptor-positive (HR plus ) early breast cancer (EBC)